Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06700356 · ClinicalTrials.gov registry record · NA
Thalamus Seizure Detection With a Deep Brain Stimulator System
A NA study of Epilepsy; Seizure, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT06700356 is a NA study of Epilepsy; Seizure that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 5 participants, below the 785-participant average among 4 other Epilepsy; Seizure trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06700356, a NA study of Epilepsy; Seizure, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-standard video-EEG monitoring collected in the in-patient setting (epilepsy monitoring unit), in 5 patients with drug resistant epilepsy.
Conditions Studied
Interventions
- DEVICE Phase 1-Validation of thalamus seizure detection with concurrent video EEG monitoring
- DEVICE Phase 2-DBS Stimulation with Medtronic Percept DBS device-Out Patient
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06700356
The ClinicalTrials.gov registry entry for NCT06700356 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 4 other Epilepsy; Seizure trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy; Seizure appearing as the primary indexed condition, and to 2 interventions - of which Phase 1-Validation of thalamus seizure detection with concurrent video EEG monitoring is the first listed.
NCT06700356 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06700356 about?
NCT06700356 is a clinical study titled "Thalamus Seizure Detection With a Deep Brain Stimulator System". The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-...
What is the current status of trial NCT06700356?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2026-06-01. Estimated completion is 2027-05.
What conditions does trial NCT06700356 study?
This clinical trial studies the following conditions: Epilepsy; Seizure.
What interventions are being tested in trial NCT06700356?
The interventions under investigation include: Phase 1-Validation of thalamus seizure detection with concurrent video EEG monitoring (DEVICE), Phase 2-DBS Stimulation with Medtronic Percept DBS device-Out Patient (DEVICE).
Who is sponsoring clinical trial NCT06700356?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06700356 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy; Seizure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Brain Stimulation Parameters
RECRUITING · NA
-
Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking
RECRUITING · NA
-
Sleep Spindles and Memory in Rolandic Epilepsy
RECRUITING · NA
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.